Broad application of multigene panel testing for breast cancer susceptibility - Pandora's box is opening wider Editorial

  

Authors:	Robson, M.; Domchek, S.
Title:	Broad application of multigene panel testing for breast cancer susceptibility - Pandora's box is opening wider
Keywords:	gene mutation; cancer risk; risk benefit analysis; note; genetic analysis; rad50 protein; rad50 gene; cancer susceptibility; breast cancer; genetic variability; practice guideline; brca1 protein; brca2 protein; protein p53; risk assessment; health care policy; health care cost; medicare; cancer genetics; oncogene; genetic susceptibility; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; atm protein; health care system; checkpoint kinase 2; genetic risk; risk reduction; breast surgery; pten gene; atm gene; clinical outcome; dna glycosylase muty; chek2 gene; tp53 gene; brip1 gene; human; mutyh gene; mre11a gene; multigene panel testing
Journal Title:	JAMA Oncology
Volume:	5
Issue:	12
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2019-12-01
Start Page:	1687
End Page:	1688
Language:	English
DOI:	10.1001/jamaoncol.2019.4004
PUBMED:	31580388
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073059582&doi=10.1001%2fjamaoncol.2019.4004&partnerID=40&md5=d37bc6b50d9a0b1a985862e089c73a5f
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/159922